Institute of Cancer Research and Royal Marsden NHS Foundation Trust, LondonJohn Wiley & Sons, Ltd.Trends in Urology & Mens HealthKirby, R, Eeles, R, Neal, D (2013) Prostate cancer UK: the blue skies forum. Trends Urol Men’s Health 4: pp. 39-43...
Semi-structured interviews with a purposively selected group of healthcare professionals involved in prostate cancer care within the NHS, conducted over the phone or face to face. A total of 37 healthcare professionals participated in the interviews including urologists, clinical oncologists, medical ...
NHS https://www.datadictionary.nhs.uk/data_elements/cancer_referral_to_treatment_period_start_date.html (2022). Redaniel, M. T., Martin, R. M., Gillatt, D., Wade, J. & Jeffreys, M. Time from diagnosis to surgery and prostate cancer survival: a retrospective cohort study. BMC ...
The NHS describes a benign enlarged prostate as a condition that can affect how people urinate, and is common among men aged over 50. "It's not a cancer and it's not usually a serious threat to health," the NHS said on its website. "Many men worry that having an enlarged prostate ...
and around 50 per cent impotence. It should be noted that NICE has yet to approve the research and pass the treatment for NHS usage. Even then, as with kidney cancer where HiFU is occasionally used in the UK, it is another thing getting the doctors to use the therapy rather than traditi...
Only a few years ago, a man newly diagnosed with prostate cancer in the UK would most likely expect (as well as fear) immediate treatment a fast track to radiotherapy, brachytherapy, hormone therapy or surgery. But Professor Robert Thomas, consultant oncologist at Bedford and Addenbrooke’s Camb...
Treatment of prostate cancer also varies by NHS Hospital Trust within England [6] and between the four UK countries. Given that health-related quality of life [7] and urinary, bowel, sexual, and hormone-related problems [7], [8], [9] are treatment related, these patient-reported outcomes...
FULL PAPER British Journal of Cancer (2017) 117, 1562–1571 | doi: 10.1038/bjc.2017.312 Keywords: risk factors; prostate cancer; cohort study; prospective; UK Biobank Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study Aurora Perez-Cornago*,1, Timothy J...
TheNHSdescribes a benign enlarged prostate as a condition that can affect how people urinate, and is common among men aged over 50. "It's not a cancer and it's not usually a serious threat to health," the NHS said on its website. ...
The treatment was launched in England through the Cancer Drugs Fund. Professor Johann de Bono, Professor of Experimental Cancer Medicine at The Institute of Cancer Research, London, and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, said:“Enzalutamide is a much-needed devel...